{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:19:15Z","timestamp":1787566755361,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR083110"],"award-info":[{"award-number":["R01 AR083110"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002369"],"award-info":[{"award-number":["UL1TR002369"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.eclinm.2026.104086","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T08:14:27Z","timestamp":1784535267000},"page":"104086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Recurrence after healing in pyoderma gangrenosum: a prospective registry-based cohort study"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8436-5626","authenticated-orcid":false,"given":"Jordan","family":"Gillespie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0140-7237","authenticated-orcid":false,"given":"Jaclyn","family":"Roland-McGowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8782-4971","authenticated-orcid":false,"given":"Katelyn","family":"Downey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile","family":"Latour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex G.","family":"Ortega-Loayza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.eclinm.2026.104086_bib1","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jaad.2016.06.016","article-title":"Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: a prospective cohort study","volume":"75","author":"Thomas","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.eclinm.2026.104086_bib2","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.2147\/CCID.S381490","article-title":"Recalcitrant pyoderma gangrenosum: clinical burden and unmet needs","volume":"16","author":"Becker","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104086_bib3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/09546630410031909","article-title":"Review of 26 cases of classical pyoderma gangrenosum: clinical and therapeutic features","volume":"15","author":"Vidal","year":"2004","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104086_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.annder.2025.103364","article-title":"Clinical course and prognostic disparities of pyoderma gangrenosum based on underlying disease: a long-term comparative study in 124 patients","volume":"152","author":"Bar","year":"2025","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.eclinm.2026.104086_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h2958","article-title":"Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial","volume":"350","author":"Ormerod","year":"2015","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104086_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/pde.14341","article-title":"Resolution of chronic recurrent pyoderma gangrenosum with latent tuberculosis treatment","volume":"38","author":"Saklecha","year":"2021","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.eclinm.2026.104086_bib7","article-title":"A case report of localized vegetative pyoderma gangrenosum of the foot in a patient with Myasthenia gravis in an outpatient setting","volume":"15","author":"Syed","year":"2023","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.eclinm.2026.104086_bib8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/1078155214541975","article-title":"Pyoderma gangrenosum due to lenalidomide use for multiple myeloma","volume":"21","author":"Dasanu","year":"2015","journal-title":"J Oncol Pharm Pract"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104086_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.25259\/IJDVL_968_20","article-title":"Clinicopathological features and prognosis of pyoderma gangrenosum in Korea: a single centre, retrospective, observational study over 20 years","volume":"89","author":"Kim","year":"2023","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"10.1016\/j.eclinm.2026.104086_bib10","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/exd.14534","article-title":"Pyoderma gangrenosum: a systematic review of the molecular characteristics of disease","volume":"31","author":"Flora","year":"2022","journal-title":"Exp Dermatol"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104086_bib11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jaad.2017.09.040","article-title":"Risk of developing pyoderma gangrenosum after procedures in patients with a known history of pyoderma gangrenosum-A retrospective analysis","volume":"78","author":"Xia","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104086_bib12","article-title":"Recurrence of pyoderma Gangrenosum potentially triggered by COVID-19 vaccination","volume":"14","author":"Clark","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.eclinm.2026.104086_bib13","article-title":"A case of recurrent pyoderma gangrenosum injection site reaction triggered by Maveropepimut-S (previously known as DPX-Survivac) in a patient undergoing immunotherapy for ovarian cancer: a case report","volume":"14","author":"Nassim","year":"2026","journal-title":"SAGE Open Med Case Rep"},{"issue":"4","key":"10.1016\/j.eclinm.2026.104086_bib14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s40257-017-0265-1","article-title":"PAPA, PASH and PAPASH syndromes: pathophysiology, presentation and treatment","volume":"18","author":"Cugno","year":"2017","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104086_bib15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/bjd.16401","article-title":"The PARACELSUS score: a novel diagnostic tool for pyoderma gangrenosum","volume":"180","author":"Jockenh\u00f6fer","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.eclinm.2026.104086_bib16","series-title":"_R: a Language and Environment for Statistical Computing_","year":"2026"},{"key":"10.1016\/j.eclinm.2026.104086_bib17","series-title":"Applied Logistic Regression","author":"Hosmer","year":"2000"},{"issue":"10","key":"10.1016\/j.eclinm.2026.104086_bib18","doi-asserted-by":"crossref","first-page":"882","DOI":"10.12968\/jowc.2022.31.10.882","article-title":"Impaired wound healing in diabetes","volume":"31","author":"Swoboda","year":"2022","journal-title":"J Wound Care"},{"issue":"11","key":"10.1016\/j.eclinm.2026.104086_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/iwj.70105","article-title":"Ageing: an independent risk factor in the management of lower extremity wounds","volume":"21","author":"Brocklehurst","year":"2024","journal-title":"Int Wound J"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104086_bib20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/wrr.12149","article-title":"Wound duration and healing rates: cause or effect?","volume":"22","author":"Bosanquet","year":"2014","journal-title":"Wound Repair Regen"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104086_bib21","doi-asserted-by":"crossref","first-page":"e436","DOI":"10.1111\/jdv.20457","article-title":"Effects of comorbidities on delayed wound healing in patients with pyoderma gangrenosum","volume":"39","author":"Zhao","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"10.1016\/j.eclinm.2026.104086_bib22","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.bjps.2017.03.013","article-title":"Pyoderma gangrenosum with pathergy: a potentially significant complication following breast reconstruction","volume":"70","author":"Patel","year":"2017","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.eclinm.2026.104086_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/bjd\/ljag084","article-title":"Minimum data set for treatment effectiveness in pyoderma gangrenosum for an international registry: an international multidisciplinary eDelphi consensus","author":"Haddadin","year":"2026","journal-title":"Br J Dermatol"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026003391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026003391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T08:25:04Z","timestamp":1787559904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537026003391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":23,"alternative-id":["S2589537026003391"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104086","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrence after healing in pyoderma gangrenosum: a prospective registry-based cohort study","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104086"}}